Endpoints for lymphatic filariasis programs
- PMID: 17553278
- PMCID: PMC2725965
- DOI: 10.3201/eid1304.061063
Endpoints for lymphatic filariasis programs
Abstract
In 2000, annual mass administration of diethlycarbamazine and albendazole began in Leogane Commune, Haiti, to interrupt transmission of lymphatic filariasis (LF). After 5 years of treatment, microfilaremia, antigenemia, and mosquito infection rates were significantly reduced, but LF transmission was not interrupted. These finding have implications for other LF elimination programs.
Figures
References
-
- World Health Organization. Global programme to eliminate lymphatic filariasis: progress report on mass drug administrations in 2005. Wkly Epidemiol Rec. 2006;81:221–32. - PubMed
-
- de Rochars MB, Kanjilal S, Direny AN, Radday J, Lafontant JG, Mathieu E, et al. The Leogane, Haiti demonstration project: decreased microfilaremia and program costs after three years of mass drug administration. Am J Trop Med Hyg. 2005;73:888–94. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources